Interesting!
I left @Apple to build healthcare that listens and acts early. Today, I'm excited to introduce UniqueHuman.
We're building proactive healthcare agents that handle every step of care for people with chronic conditions.
Our mission is to end chronic suffering. Today, we begin with migraines.
86
Replying to @canarabank
@canarabank Dear Canara Bank! It’s extremely dissatisfying that almost every month we need to re-register on the app! Can’t that be permanently fixed?! Either all the banking apps in the world are wrong or you are not doing something right!
3
106
Dear Team
Again I have been logged out with the App asking me to log in again. Highly disappointing. no other Indian or foreign bank do this @canarabank @CBOFofficial @nsitharaman @nsitharamanoffc @RBI
3
66
Every time you log on, you need to enter a new MPIN AND PIN! Cannot be doing every month! Pls fix it! @canarabank @TNMANOHARAN
15
Prof Amrith Rao retweeted
These videos from the AUA are amazing youtube.com/watch?v=cWnHAG_y…
Prof Amrith Rao retweeted
⭐ Top 5 advances in renal cell carcinoma that shaped clinical practice in 2025
From adjuvant immunotherapy to updated guidelines and key translational insights, these advances are reshaping how we treat RCC, with a direct impact on clinical decision-making and patient selection.
🔬 Evidence
🧬 Biology
⚖️ Clinical practice
👉 Full article ⬇️
nitter.cf/nataliagandur/status/2…
Insights relevant for daily practice in RCC.
@DrChoueiri @BrianRini @neerajaiims @tompowles1 @PGrivasMDPhD @montypal @JCO_ASCO @OncoAlert @Uromigos @MedicalwatchHQ
Prof Amrith Rao retweeted
ESMO Clinical Practice Guideline: Local and locoregional prostate cancer!
@myESMO @APCCC_Lugano @AttardLab @Ecastromarcos @stefanofanti4 @Silke_Gillessen @Prof_Nick_James @piet_ost @MarkARubin1 @ChrisSweens1 @Tilki_De @ZilliThomas @alison_tree @OncoAlert
doi.org/10.1016/j.annonc.202…
Prof Amrith Rao retweeted
Localised prostate cancer just changed. Again.
ESMO 2026 brings clarity on who to observe, who to escalate, and which trials actually matter 👇
🧠 Diagnosis
MRI before biopsy is standard
High-resolution US is a valid alternative (RCT n=678)
🧭 Low risk
Active surveillance is safe
ProtecT 15-yr data shows similar survival vs RP/RT
☢️ Radiotherapy
Shorter is better
CHHiP ➜ moderate hypofractionation
HYPO-RT-PC ➜ ultra-hypofractionation
PACE-B ➜ SBRT works in selected IR disease
📈 High risk
RT + long-term ADT saves lives
SPCG-7 | NCIC/MRC
Dose escalation improves OS (GETUG-AFU 18)
🚨 Very high-risk / cN1
RT + ADT + abiraterone is the new benchmark
STAMPEDE delivers MFS + OS benefit
🔁 Biochemical recurrence
Avoid routine adjuvant RT
Early salvage RT preferred
RADICALS-RT | RAVES | GETUG-AFU 17
High-risk BCR? Intensify
EMBARK supports enzalutamide + ADT
🧠 Bottom line
Risk-adapted care > overtreatment
Imaging-driven decisions
Escalate only when trials prove benefit
📖 Full paper in comment ⬇️
#OncoTwitter #MedTwitter #ProstateCancer #GUOncology
@OncoAlert @myesmo @esmo_open @asco @OncBrothers
Prof Amrith Rao retweeted
Hyperbaric oxygen therapy for chronic radiotherapy‐related adverse effects: A clinically focused review
pmc.ncbi.nlm.nih.gov/article…
Prof Amrith Rao retweeted
📢 New SOC for MIBC
#ESMO25 Dr. Christof Vulsteke presents KEYNOTE-905:
🚫 No cisplatin? No problem. EV+pembro delivers.
👥 n=344 cis-ineligible MIBC (80% renal impairment, 15% ECOG 2)
🔹 EFS HR 0.40 | OS HR 0.50
🔹 pCR: 57.1% vs 8.6% (ITT, non-op = non-responders)
🔹 No ↑ surgical complications
✅ 1st phase 3 trial showing OS benefit in this population| Unprecedented pCR↑
@urotoday @myESMO
Prof Amrith Rao retweeted
In a trial of men with suspected prostate cancer, biparametric MRI, which excludes the gadolinium contrast sequence, was noninferior to multiparametric MRI for detecting clinically significant cases. 🧵
ja.ma/4nhCVqy
Only ONE immigration officer for non EU passport holders at Schipol Airport, Amsterdam! Definitely they can do better! @Schiphol @Iamsterdam @Visit_NL @usambnl @DutchMFA @DutchNewsNL
1
2
217
Sad day for Urology! A silent giant indeed 🙏🏼
A very sad day learning that a giant in urology passed, Donald G. Skinner MD His impact was profound. His commitment to surgical excellence was only matched by his devotion to pt care and teaching. Simply the best mentor, colleague and friend
RIP Boss
@UroOnc @AmerUrological
178
Interesting thread!
I learned this week that SABR-COMET patient #1 recently passed away, more than 12 years after enrollment, with no recurrence since his original SABR.
We initially treated him for a left adrenal met. It’s an interesting story… ⬇️⬇️⬇️
1
111
Replying to @airtelindia
@airtelindia @JM_Scindia @airtelnews @DoT_India @PMOIndia @narendramodi @AmitShah
Airtel India has one of the worst customer services. I am a NRI and have been on intl roaming for 5 years & givin good business. But the service is horrendous!
4
1
148
@airtelindia @Airtel_Presence @SunilBhartiMitl @PMOIndia @JM_Scindia Dear Airtel Team - I was assured that someone would call me regarding the issue I am facing and no call has been recieved. Extremely poor service for NRIs like me who would want to keep in touch with India.
Prof Amrith Rao retweeted
Out now and open access 👇: Cardiovascular Risks and Survival with Abiraterone vs Enzalutamide in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer in Germany: AVENGER Study
@Uroweb @OncoAlert @brunolarvol @urotoday @UKSH_KI_HL
rdcu.be/ebWMr
Prof Amrith Rao retweeted
Great summary re: avoiding false positive PSMA pitfalls from Irene Burger #APCCCDiagnostics25
Very nice thread! 👍🏽
🚨 The 2024 FROGG Guidelines for Post-Prostatectomy Radiation Therapy (PPRT) are here, bringing groundbreaking updates backed the by the latest evidence❗️@OncoAlert 🧵1/7
1
147




































